𝔖 Bobbio Scriptorium
✦   LIBER   ✦

‘Novel alkyl side chain sulfone 1α,25-dihydroxyvitamin D3 analogs: A comparison of in vitro antiproliferative activities and in vivo calcemic activities’

✍ Scribed by Aimee R. Usera; Patrick Dolan; Thomas W. Kensler; Gary H. Posner

Book ID
108072666
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
312 KB
Volume
17
Category
Article
ISSN
0968-0896

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differentiating and antitumor activities
Differentiating and antitumor activities of 1α,25-dihydroxyvitamin D3 in vitro and 1α-hydroxyvitamin D3 in vivo on human osteosarcoma
✍ Dr. Hiroyuki Tsuchiya; Hajime Morishita; Katsuro Tomita; Yoshimichi Ueda; Motohi 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 813 KB

## Abstract The differentiating and antitumor activities of 1α,25‐dihydroxyvitamin D~3~ (1α,25(OH)~2~D~3~) in vitro and 1α‐hydroxyvitamin D~3~ (1α(OH)D~3~) in vivo were studied with a human osteosarcoma cell line (OST strain). Antitumor activity was estimated with the use of 3‐(4,5‐dimethylthiazol)

Molecular and functional comparison of 1
Molecular and functional comparison of 1,25-dihydroxyvitamin D3 and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4
✍ Peter W. Jurutka; Paul D. Thompson; G. Kerr Whitfield; Kristina R. Eichhorst; Ne 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 940 KB

The vitamin D receptor (VDR) binds to and mediates the effects of the 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) hormone to alter gene transcription. A newly recognized VDR ligand is the carcinogenic bile acid, lithocholic acid (LCA). We demonstrate that, in HT-29 colon cancer cells, both LCA and 1